736.08美元11.08(1.48%)
2024/07/25更新
績效 / 1月0.76%
3月6.31%
1年13.65%
晨星評等 - 1.現金0.00%
- 2.股票28.11%
- 3.債券0.00%
- 4.其他71.89%
- 1.美國71.89%
- 2.歐洲不包含歐元區18.44%
- 3.英國4.93%
- 4.歐元區1.48%
- 5.日本1.41%
- 1.Eli Lilly and Co9.70%
- 2.Novo Nordisk A/S Class B8.99%
- 3.UnitedHealth Group Inc7.57%
- 4.Merck & Co Inc6.38%
- 5.Roche Holding AG5.03%
- 6.Regeneron Pharmaceuticals Inc4.96%
- 7.Vertex Pharmaceuticals Inc4.81%
- 8.Elevance Health Inc4.26%
- 9.Intuitive Surgical Inc3.97%
- 10.Gilead Sciences Inc3.91%
- 1.現金0.00%
- 2.股票28.11%
- 3.債券0.00%
- 4.其他71.89%
- 1.美國71.89%
- 2.歐洲不包含歐元區18.44%
- 3.英國4.93%
- 4.歐元區1.48%
- 5.日本1.41%
- 1.Eli Lilly and Co9.70%
- 2.Novo Nordisk A/S Class B8.99%
- 3.UnitedHealth Group Inc7.57%
- 4.Merck & Co Inc6.38%
- 5.Roche Holding AG5.03%
- 6.Regeneron Pharmaceuticals Inc4.96%
- 7.Vertex Pharmaceuticals Inc4.81%
- 8.Elevance Health Inc4.26%
- 9.Intuitive Surgical Inc3.97%
- 10.Gilead Sciences Inc3.91%